Clinical Trial: Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb): a Prospective Cohort Study

Brief Summary: Study of seroprevalence of hepatitis E among HIV positive patient in Basque country, France in 2016.

Detailed Summary: Study of seroprevalence of hepatitis E among patient followed and treated in "centre Hospitalier de la Côte Basque" for HIV infections. Study of acquisition of hepatitis E , and determination of liver status using fibrotest in co-infected patients with hepatis C and / or B.
Sponsor: Centre Hospitalier de la côte Basque

Current Primary Outcome: Prevalence of immunoglobulin M (IgM) and Immunoglobulin G (IgG) for hepatitis E in blood sample of each patients. Positive sample for both IgM and IgG will be confirmed using polymerase chain reaction (PCR) techniques [ Time Frame: 6 months time period ]

Blood samples will be tested for specific immunoglobulins against hepatitis E virus


Original Primary Outcome: Same as current

Current Secondary Outcome: fibrotest score [ Time Frame: 6 months time period ]

patients infected with hepatitis B or hepatitis C viruses will have their liver status determined using fibrotest score.


Original Secondary Outcome: Same as current

Information By: Centre Hospitalier de la côte Basque

Dates:
Date Received: July 20, 2016
Date Started: July 2016
Date Completion: January 2017
Last Updated: July 27, 2016
Last Verified: July 2016